147 related articles for article (PubMed ID: 33453721)
1. The critical role of hippocampal dopamine in the pathogenesis of hepatic encephalopathy.
Chen B; Yang Y; Li S; Zhu X; Qi Y; Hong F
Physiol Res; 2021 Mar; 70(1):101-110. PubMed ID: 33453721
[TBL] [Abstract][Full Text] [Related]
2. Essential role of D1 but not D2 receptors in the NMDA receptor-dependent long-term potentiation at hippocampal-prefrontal cortex synapses in vivo.
Gurden H; Takita M; Jay TM
J Neurosci; 2000 Nov; 20(22):RC106. PubMed ID: 11069975
[TBL] [Abstract][Full Text] [Related]
3. Differential involvement of D1 and D2 dopamine receptors in L-DOPA-induced angiogenic activity in a rat model of Parkinson's disease.
Lindgren HS; Ohlin KE; Cenci MA
Neuropsychopharmacology; 2009 Nov; 34(12):2477-88. PubMed ID: 19606087
[TBL] [Abstract][Full Text] [Related]
4. The anti-dyskinetic effect of dopamine receptor blockade is enhanced in parkinsonian rats following dopamine neuron transplantation.
Shin E; Lisci C; Tronci E; Fidalgo C; Stancampiano R; Björklund A; Carta M
Neurobiol Dis; 2014 Feb; 62():233-40. PubMed ID: 24135006
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effects between CA1 mu opioid and dopamine D1-like receptors in impaired passive avoidance performance induced by hepatic encephalopathy in mice.
Nasehi M; Amin Yavari S; Zarrindast MR
Psychopharmacology (Berl); 2013 Jun; 227(3):553-66. PubMed ID: 23404062
[TBL] [Abstract][Full Text] [Related]
6. Small dose of L-dopa/Benserazide hydrochloride improved sepsis-induced neuroinflammation and long-term cognitive dysfunction in sepsis mice.
Li F; Zhang B; Duan S; Qing W; Tan L; Chen S; Wang Y; Li D; Yang J; Tong J; Fang J; Le Y
Brain Res; 2020 Jun; 1737():146780. PubMed ID: 32205148
[TBL] [Abstract][Full Text] [Related]
7. In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to L-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels.
Mela F; Marti M; Bido S; Cenci MA; Morari M
Neurobiol Dis; 2012 Jan; 45(1):573-82. PubMed ID: 22001605
[TBL] [Abstract][Full Text] [Related]
8. Dopamine acting at D1-like, D2-like and α1-adrenergic receptors differentially modulates theta and gamma oscillatory activity in primary motor cortex.
Özkan M; Johnson NW; Sehirli US; Woodhall GL; Stanford IM
PLoS One; 2017; 12(7):e0181633. PubMed ID: 28732063
[TBL] [Abstract][Full Text] [Related]
9. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
Hu XT; White FJ
Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
[TBL] [Abstract][Full Text] [Related]
10. In vivo dopamine agonist properties of rotigotine: Role of D1 and D2 receptors.
Fenu S; Espa E; Pisanu A; Di Chiara G
Eur J Pharmacol; 2016 Oct; 788():183-191. PubMed ID: 27343381
[TBL] [Abstract][Full Text] [Related]
11. Comparative biochemical pharmacology of central nervous system dopamine D1 and D2 receptors.
Reader TA; Molina-Holgado E; Dewar KM
Mol Neurobiol; 1992; 6(4):425-50. PubMed ID: 1285933
[TBL] [Abstract][Full Text] [Related]
12. Decreased binding of dopamine D3 receptors in limbic subregions after neonatal bilateral lesion of rat hippocampus.
Flores G; Barbeau D; Quirion R; Srivastava LK
J Neurosci; 1996 Mar; 16(6):2020-6. PubMed ID: 8604046
[TBL] [Abstract][Full Text] [Related]
13. Striatal dopamine D1 and D2 receptors: widespread influences on methamphetamine-induced dopamine and serotonin neurotoxicity.
Gross NB; Duncker PC; Marshall JF
Synapse; 2011 Nov; 65(11):1144-55. PubMed ID: 21584865
[TBL] [Abstract][Full Text] [Related]
14. Dopamine D1 and D2 receptor contributions to L-DOPA-induced dyskinesia in the dopamine-depleted rat.
Taylor JL; Bishop C; Walker PD
Pharmacol Biochem Behav; 2005 Aug; 81(4):887-93. PubMed ID: 16023708
[TBL] [Abstract][Full Text] [Related]
15. Denervation and repeated L-DOPA induce complex regulatory changes in neurochemical phenotypes of striatal neurons: implication of a dopamine D1-dependent mechanism.
St-Hilaire M; Landry E; Lévesque D; Rouillard C
Neurobiol Dis; 2005 Nov; 20(2):450-60. PubMed ID: 15896973
[TBL] [Abstract][Full Text] [Related]
16. Effects of hippocampal kainic acid lesions on striatolimbic dopamine D1-, D2-, and D4-like receptors.
Tarazi FI; Campbell A; Baldessarini RJ
Neuroscience; 1998 Nov; 87(1):1-4. PubMed ID: 9722137
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of 50-kHz ultrasonic vocalizations by dopamine receptor subtype-selective agonists and antagonists in adult rats.
Scardochio T; Clarke PB
Psychopharmacology (Berl); 2013 Apr; 226(3):589-600. PubMed ID: 23192317
[TBL] [Abstract][Full Text] [Related]
18. Dopaminergic modulation of nitric oxide synthase activity in subregions of the rat nucleus accumbens.
Hoque KE; West AR
Synapse; 2012 Mar; 66(3):220-31. PubMed ID: 22034069
[TBL] [Abstract][Full Text] [Related]
19. Serotonin 2A receptor antagonist treatment reduces dopamine D1 receptor-mediated rotational behavior but not L-DOPA-induced abnormal involuntary movements in the unilateral dopamine-depleted rat.
Taylor JL; Bishop C; Ullrich T; Rice KC; Walker PD
Neuropharmacology; 2006 May; 50(6):761-8. PubMed ID: 16434065
[TBL] [Abstract][Full Text] [Related]
20. Alterations in the turnover rate of dopamine D1 but not D2 receptors in the adult rat neostriatum after a neonatal dopamine denervation.
Dewar KM; Paquet M; Reader TA
Neurochem Int; 1997 Jun; 30(6):613-21. PubMed ID: 9153003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
